Market revenue in 2023 | USD 1,011.8 million |
Market revenue in 2030 | USD 2,766.0 million |
Growth rate | 15.5% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.39% in 2023. Horizon Databook has segmented the China cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The cell culture market in China is highly saturated with local players, although the low cost of production drives global investments in the country for manufacturing. For instance, in December 2021, Fujifilm announced building a new center for bioprocessing media in China. The plant is aimed at providing media for biotherapeutics development, advanced therapies, & vaccines.
Moreover, China is a pioneer in stem cell research, which is projected to drive the demand for cell culture products. The presence of global players, such as Thermo Fisher Scientific, Inc. & Merck KGaA, and local suppliers, such as Global Kang Qinhuangdao Biotechnology Co., Ltd. & Guangzhou Ikeme Technology Co., Ltd., aids in meeting the diverse needs of R&D in the biopharmaceutical industry in the country.
Furthermore, China is intensifying research in cancer and cell therapies. In 2019, the Beijing Xisike Clinical Oncology Research Foundation granted funds to support the expansion of clinical and scientific research in China. In addition, several Chinese pharmaceutical companies have conducted extensive research activities to develop novel vaccines or therapies for COVID-19. Increased R&D initiatives are anticipated to significantly fuel the demand for cell culture products in the country, thus supporting market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the China cell culture market , including forecasts for subscribers. This country databook contains high-level insights into China cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account